Robert Lorne Hopfner, Director at Vaxcyte, Inc. (PCVX), sold 663,656 shares at $28.07 ($18.0M) on 2021-02-09, disclosed to the SEC on 2021-02-10.
Open-market sale of $18.0M PCVX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.64 | 50,874 | $1.3M | 7.2% |
| 2 | $25.64 | 50,874 | $1.3M | 7.2% |
| 3 | $26.06 | 28,922 | $754K | 4.2% |
| 4 | $26.06 | 28,922 | $754K | 4.2% |
| 5 | $27.12 | 38,248 | $1.0M | 5.8% |
| 6 | $27.12 | 38,248 |
| $1.0M |
| 5.8% |
| 7 | $28.07 | 88,756 | $2.5M | 13.8% |
| 8 | $28.07 | 88,756 | $2.5M | 13.8% |
| 9 | $28.75 | 93,740 | $2.7M | 15.0% |
| 10 | $25.75 | 37,271 | $960K | 5.3% |
| 11 | $25.75 | 37,271 | $960K | 5.3% |
| 12 | $26.78 | 26,688 | $715K | 4.0% |
| 13 | $26.78 | 26,688 | $715K | 4.0% |
| 14 | $27.64 | 7,567 | $209K | 1.2% |
| 15 | $27.64 | 7,567 | $209K | 1.2% |
| 16 | $28.66 | 6,632 | $190K | 1.1% |
| 17 | $28.66 | 6,632 | $190K | 1.1% |
| Total | $27.15 avg | 663,656 | $18.0M | 100% |
| Filing → |
| INZY | BUY | 2023-05-15 | $5.7M | — | Filing → |
| INZY | BUY | 2023-03-30 | $3.1M | — | Filing → |
| INZY | BUY | 2023-03-29 | $1.7M | — | Filing → |